Clinical Trials Browser

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Melanoma, Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Colorectal Neoplasms

NCT04516681 2024-10-24

Combination of IV Ascorbic Acid and Adebrelimab in Metastatic Colorectal Cancer

Phase 3 Recruiting

400 enrolled

Gastrointestinal

Colorectal Neoplasms

NCT03635021 2024-10-21

CR-SEQUENCE

Phase 3 Active not recruiting

419 enrolled

Gastrointestinal

Colorectal Neoplasms

NCT06509880 2024-07-19

ISMCC

Phase 1/2 Active not recruiting

200 enrolled

Gastrointestinal

Colorectal Neoplasms

NCT05039944 2024-07-18

SI-B001 as a Single Agent or in Combination With Chemotherapy in the Treatment of Digestive System Malignancies

Phase 2 Terminated

7 enrolled

Gastrointestinal

Colorectal Neoplasms

NCT03043950 2024-04-24

VALIDATE

Completed

647 enrolled

Gastrointestinal

Colorectal Neoplasms

NCT01515787 2024-02-02

PROSPECT: Chemotherapy Alone or Chemotherapy Plus Radiation Therapy in Treating Patients With Locally Advanced Rectal Cancer Undergoing Surgery

Phase 2/3 Unknown

1,194 enrolled 25 charts

Gastrointestinal

Rectal Neoplasms, Colorectal Neoplasms

NCT06218810 2024-01-23

Cadonilimab in Combination With Bevacizumab and FOLFOX Regimen for the First-Line Treatment of Advanced Unresectable MSS-Type, RAS-Mutated Metastatic Colorectal Cancer

Phase 2 Recruiting

53 enrolled

Gastrointestinal

Colorectal Neoplasms

NCT06115174 2023-11-02

CRC - PTX

Phase 4 Unknown

44 enrolled

Gastrointestinal

Colorectal Neoplasms

NCT00958737 2023-09-29

IDEA

Phase 3 Unknown

2,000 enrolled

Gastrointestinal

Colonic Neoplasms, Colorectal Neoplasms

NCT01622543 2023-08-23

Reolysin in Combination With FOLFOX6 and Bevacizumab or FOLFOX6 and Bevacizumab Alone in Metastatic Colorectal Cancer

Phase 2 Completed

109 enrolled 13 charts

Gastrointestinal

Colorectal Neoplasms

NCT05832398 2023-06-28

Precision Chemotherapy Based on Organoid Drug Sensitivity for Colorectal Cancer

Phase NA Unknown

186 enrolled

Gastrointestinal

Colorectal Neoplasms

NCT01420874 2023-05-06

Anti-CD3 x Anti-Erbitux® Armed Activated T Cells (Phase Ib) for Gastrointestinal (GI Cancer)

Phase 1 Completed

15 enrolled

Gastrointestinal

Colonic Neoplasms, Pancreatic Neoplasms, Colorectal Neoplasms

NCT05815082 2023-04-18

ctDNA-guided Adjuvant Chemotherapy in Liver Metastasis of Colorectal Cancer

Phase 3 Recruiting

490 enrolled

Gastrointestinal

Neoplastic Cells, Circulating, Colorectal Neoplasms

NCT05797077 2023-04-04

Postoperation Maintenance Therapy for Resectable Liver Metastases of Colorectal Cancer Guided by ctDNA

Phase 3 Recruiting

346 enrolled

Gastrointestinal

Neoplastic Cells, Circulating, Colorectal Neoplasms, Neoplasms, Second Primary

NCT05797883 2023-04-04

FOLFOX/FOLFIRI Containing Levofolinic Acid (Zuoyu ®) in the Treatment of Unresectable or Metastatic Colorectal Cancer

Phase 2 Unknown

30 enrolled

Gastrointestinal

Colorectal Neoplasms

NCT03202758 2023-02-10

MEDITREME

Phase 1/2 Completed

57 enrolled

Gastrointestinal

Colorectal Neoplasms

NCT05721872 2023-02-10

Efficacy, Tolerability and Safety of Intravenous D-VC With ATO in Patients With Advanced/Metastatic Colorectal Cancer

Phase 1/2 Unknown

38 enrolled

Gastrointestinal

Colorectal Neoplasms

NCT00851136 2022-12-13

A Study of PRO95780 Administered in Combination With the FOLFOX Regimen and Bevacizumab in Patients With Previously Untreated, Locally Advanced, Recurrent, and Metastatic Colorectal Cancer (APM4566g)

Phase 1 Completed

9 enrolled

Gastrointestinal

Colonic Neoplasms, Colorectal Neoplasms

NCT00364013 2022-11-07

PRIME: Panitumumab Randomized Trial In Combination With Chemotherapy for Metastatic Colorectal Cancer to Determine Efficacy

Phase 3 Completed

1,183 enrolled 18 charts

Gastrointestinal

Neoplasms, Colorectal Neoplasms

NCT03254394 2022-03-09

Lidocaine for Oxaliplatin-induced Neuropathy

Phase 1/2 Completed

26 enrolled 10 charts

Gastrointestinal

Neuropathy, Painful, Cold Hypersensitivity, Neuralgia, Colorectal Neoplasms

NCT00070213 2021-09-27

Leucovorin and Fluorouracil With or Without Oxaliplatin Compared to Capecitabine With or Without Oxaliplatin in Treating Patients With Metastatic Colorectal Cancer

Phase 3 Completed

460 enrolled

Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

Clinical Trials

Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors

BBO-11818 in Adult Subjects With KRAS Mutant Cancer

A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer

A Study to Evaluate INCB161734 in Participants With Advanced or Metastatic Solid Tumors With KRAS G12D Mutation

A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer

A Study of JNJ-89402638 for Metastatic Colorectal and Gastric Cancers

A Study Evaluating the Safety and Efficacy of Targeted Therapies in Subpopulations of Patients With Metastatic Colorectal Cancer (INTRINSIC)

ASCEND-CRC: Profiling and Targeting Dynamic Tumor Resistance in Patients With Metastatic Colorectal Cancer

INAVO-CRC

Intensified Chemotherapy in CRC After Resection of Liver Metastases

Study of Onvansertib in Combination With FOLFIRI and Bevacizumab or FOLFOX and Bevacizumab Versus FOLFIRI and Bevacizumab or FOLFOX and Bevacizumab for First-Line Treatment of Metastatic Colorectal Cancer in Adult Participants With a KRAS or NRAS Mutation

JAB-21822 Combined With Chemotherapy and Bevacizumab in Second-line KRAS G12C CRC

NALIRIFOX Plus Targeted Therapy Versus FOLFOX Plus Targeted Therapy as First-line Treatment for Metastatic Colorectal Cancer

FOXHIPECT4

LIVERPEARL

XS-03-II201

DeFianCe

SAMCO

OPTIPRIME

Hypo-OPRA

COSENSE-1

Adjuvant Hepatic Arterial Infusion and Combination Chemotherapy in Treating Patients With Resectable Hepatic Metastases From Colorectal Cancer

EGIA-003

Phase I Trial of 5-Fluorouracil (5FU) -Based Therapy in Combination With Hydroxytyrosol (HT) in Patients With Advanced or Metastatic Colorectal Cancer

A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors

FUDOSE

Standard Therapy With or Without Surgery and Mitomycin C in Treating Patients With Advanced Limited Peritoneal Dissemination of Colon Cancer

REPROGRAM-02

IVY

Combination of IV Ascorbic Acid and Adebrelimab in Metastatic Colorectal Cancer

CR-SEQUENCE

ISMCC

SI-B001 as a Single Agent or in Combination With Chemotherapy in the Treatment of Digestive System Malignancies

VALIDATE

PROSPECT: Chemotherapy Alone or Chemotherapy Plus Radiation Therapy in Treating Patients With Locally Advanced Rectal Cancer Undergoing Surgery

Cadonilimab in Combination With Bevacizumab and FOLFOX Regimen for the First-Line Treatment of Advanced Unresectable MSS-Type, RAS-Mutated Metastatic Colorectal Cancer

CRC - PTX

IDEA

Reolysin in Combination With FOLFOX6 and Bevacizumab or FOLFOX6 and Bevacizumab Alone in Metastatic Colorectal Cancer

Precision Chemotherapy Based on Organoid Drug Sensitivity for Colorectal Cancer

Anti-CD3 x Anti-Erbitux® Armed Activated T Cells (Phase Ib) for Gastrointestinal (GI Cancer)

ctDNA-guided Adjuvant Chemotherapy in Liver Metastasis of Colorectal Cancer

Postoperation Maintenance Therapy for Resectable Liver Metastases of Colorectal Cancer Guided by ctDNA

FOLFOX/FOLFIRI Containing Levofolinic Acid (Zuoyu ®) in the Treatment of Unresectable or Metastatic Colorectal Cancer

MEDITREME

Efficacy, Tolerability and Safety of Intravenous D-VC With ATO in Patients With Advanced/Metastatic Colorectal Cancer

A Study of PRO95780 Administered in Combination With the FOLFOX Regimen and Bevacizumab in Patients With Previously Untreated, Locally Advanced, Recurrent, and Metastatic Colorectal Cancer (APM4566g)

PRIME: Panitumumab Randomized Trial In Combination With Chemotherapy for Metastatic Colorectal Cancer to Determine Efficacy

Lidocaine for Oxaliplatin-induced Neuropathy

Leucovorin and Fluorouracil With or Without Oxaliplatin Compared to Capecitabine With or Without Oxaliplatin in Treating Patients With Metastatic Colorectal Cancer